Optimized solution for cancer research
Sensitive detection of low-frequency mutant alleles has extensive implications for cancer research. The accumulation of mutations in oncogenes or tumor suppressor genes is an important aspect of tumorigenesis. The TaqMan Digital PCR Liquid Biopsy assays, combined with the Oncomine cfDNA solutions, offer a comprehensive set of tools for liquid biopsy applications, and in the future may enable noninvasive techniques towards personalized medicine.
The TaqMan dPCR Liquid Biopsy Assays have been wet-lab tested and guaranteed to perform on the Applied Biosystems QuantStudio 3D and Bio-Rad* QX-100 and QX-200 systems. Download the quick reference guides on how to use TaqMan dPCR Liquid Biopsy Assays for QuantStudio 3D or Bio-Rad QX-100™ and QX-200™ systems* today.